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Lactobacillus helveticus BGRA43 is a human intestinal isolate showing antimicrobial
activity, amongst others, against Yersinia enterocolitica, Shigella sonnei, Shigella ﬂexneri,
and Streptococcus pneumoniae. BGRA43 produces PrtH proteinase with proteolytic
activity on both casein and β-lactoglobulin (BLG). BGRA43 is able to reduce the allergenicity
of BLG. Bioactive peptides released in BGRA43 fermented milk are potent modulators of
innate immunity bymodulating the production of proinﬂammatory cytokines IL-6 andTNF-α.
BGRA43 is able to survive in simulated gastric and intestinal conditions. The growth of
BGRA43 in milk results in a fast acidiﬁcation lowering the milk pH to 4.53 generating mild,
homogeneous, and viscous yogurt-like product. The strain BGRA43 grows suitably in pure
cow or goat’s milk as well as in milk containing inulin or nutrim even when they are used as
the sole carbon source. It is suggested that strain BGRA43 could be used as a single-strain
culture for the preparation of yogurt-like products from bovine or caprine milk. Overall, L.
helveticus BGRA43 could be considered as a potential probiotic candidate with appropriate
technological properties attractive for the dairy industry.
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INTRODUCTION
Lactobacillus helveticus belongs to a homofermentative L. aci-
dophilus/L. delbrueckii subgroup of lactobacilli (Felis and Del-
laglio, 2007) associated to fermented milk, meat, and plant
products as well as the gastrointestinal (GI) and urogenital (UG)
tracts of humans and animals. L. helveticus has been tradition-
ally used as a starter in the production of Italian and Swiss-type
cheeses (Giraffa et al., 1998; Beresford et al., 2001). In the last
10 years, the scientiﬁc knowledge about different L. helveticus
strains with health-promoting properties have accumulated (de
Moreno de LeBlanc et al., 2005; Guglielmetti et al., 2010; Ohland
and MacNaughton, 2010; Slattery et al., 2010). Signiﬁcant fea-
tures that provide for the broad use of L. helveticus in food and
feed biotechnology are often complemented with demonstrable
probiotic characteristics such as antimicrobial, immunomod-
ulatory, and antihypertensive activities (LeBlanc et al., 2004;
Atassi et al., 2006; Fitzgerald and Murray, 2006). In order to
identify the key genes and mechanisms contributing to the
technological properties and interactions with a host, complete
genome sequencing of different L. helveticus strains has been
performed. Moreover, detailed functional assays implicate the
potential nutritional and health beneﬁts of products containing
L. helveticus strains (Callanan et al., 2008; Prajapati et al., 2011;
Zhao et al., 2011).
CHARACTERIZATION OF THE L. helveticus BGRA43
The strain L. helveticus BGRA43 is a natural isolate originating
from the intestinal tract of healthy man. The strain was isolated by
classical microbiological methods, and previously characterized
as L. acidophilus only according to carbohydrate fermentation
pattern (Banina et al., 1998). Later on, the strain was reclassiﬁed
and phylogenetically identiﬁed by complete 16S rDNA sequenc-
ing, combined withAFLP,PFGE, and SDS analyses, as L. helveticus,
and deposited in the Belgian Coordinated Collections of Microor-
ganisms (BCCM), Gent, Belgium, as LMG P-24226 (Lozo et al.,
2011). The general characteristics of BGRA43 are as follows: (a)
growth is optimal under anaerobic conditions in the presence of
10% CO2; (b) it grows in the presence of 2% NaCl, but not in the
presence of either 4 or 6.5% NaCl; (c) during its growth in milk,
it forms a homogeneous curd showing extensive auto-aggregation
giving the curd a slimy appearance, and (d) it efﬁciently hydrolyzes
lactose. The BGRA43 strain grows well in MRS broth at 37 and
45◦Cafter successive sub-cultivations but not at 15◦C.The optimal
growth conditions for the BGRA43 strain have been determined
and results show that the shortest generation time can be achieved
when the cells are grown in MRS broth at 37◦C. The stationary
growth phase is reached after 12 h. However, it was shown that dur-
ing its growth at 42◦C, the log period is longer and the stationary
growth phase is attained after 14 h, although at this tempera-
ture the total cell number is slightly higher compared to growth
at 37◦C.
A detailed characterization of the BGRA43 strain was also
performed, including tests of its antimicrobial and proteolytic
activity, as well as a study of its probiotic and technological
properties. The results revealed that BGRA43 exhibits signiﬁ-
cant antimicrobial activity against a variety of microorganisms,
including Staphylococcus aureus, Escherichia coli C600, Bacillus
mycoides, Pseudomonas sp., Yersinia enterocolitica, Shigella sonnei,
and Shigella ﬂexneri, as well as Streptococcus pneumoniae. In
addition, the experiment performed in sulﬁte agar showed
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that BGRA43 exhibited an inhibitory effect on the growth of
Clostridium sporogenes, widely distributed in nature as a food con-
taminant, as well as a human and animal pathogen. It was found
that any growth of clostridia could not be detected in co-culture
with BGRA43 (Banina et al., 1998). Additionally, the nature of
the BGRA43 antimicrobial activity was tested using fresh bacterial
cultures (grown for 9, 12, and 16 h) from which cell-free and neu-
tralized cell-free ﬁltrates were prepared and examined in parallel.
The possibility that the compound possessing an antimicrobial
activity is of a proteinaceous nature was excluded, since in the
well-diffusion assay for detection of bacteriocins the characteristic
reduction of the inhibitory zone of indicator strain growth was
absent after the addition of the proteolytic enzymes – pronase E,
proteinase K, trypsin, and pepsin (Strahinic et al., 2012).
While combination of lactic and acetic acids can reduce bac-
terial growth, lower degree of dissociation of these acids (under
pH 4–4.6) might be associated with strong antimicrobial activ-
ity (Ouwehand, 1998). Inhibitory effect of BGRA43 is completely
lost when supernatant was used instead of fresh bacterial culture.
These results suggested that organic acid/s are involved in antimi-
crobial activity of BGRA43. We can only speculate that synergistic
effect of lactic and acetic acid in combination with some currently
unknown compounds provided antimicrobial activity to a wide
range of bacteria.
It is well known that the proteolytic activity of lactobacilli, in
terms of the degradation of casein fractions, plays an important
role in the development of texture and ﬂavor during the fermen-
tation process and is very often essential for optimal growth in
milk. Well-deﬁned proteinases of lactobacilli are the cell-envelope
proteinases (CEP) that possess different domain organization. The
characterization of the proteolytic activity of L. helveticus BGRA43
included the analysis of αs1-, β-, κ- and total-casein degradation.
Additionally, the gene(s) encoding for CEP present in the BGRA43
genome were determined. The results revealed that the whole cells
of BGRA43 possessed a strong caseinolytic activity. It was shown
that BGRA43 was able of completely hydrolyzing αs1- and β-casein
fractions after 1 h of incubation in 100mmolNa-phosphate buffer,
pH 6.5 at 45◦C. The whole cells also hydrolyzed κ-casein under the
same conditions but after 2 h of incubation. The obtained results
suggested that the release of the proteinase from the cell enve-
lope of BGRA43 is not Ca2+ dependent. The activity of the crude
proteinase extract was partially inhibited in the presence of Cu2+
and Zn2+ ions, but also by EDTA, EGTA as well as PMSF (Fira
et al., 2001).
From a genetic point of view the organization of genes encod-
ing CEP in the BGRA43 strain appears to be different from all
L. helveticus strains described so far. Until now, two CEPs have
been described and completely analyzed in L. helveticus, PrtH2
and PrtH. Both belong to the subtilisin-like serine proteinase
family with whom they share 22% amino acid sequence identity.
According to the work of Genay et al. (2009), the prtH2 gene is a
ubiquitous gene inL. helveticus, and it is present in all tested strains,
whereas the presence of the prtH gene is strain-dependent. In our
study, PCR analysis with primers corresponding to the speciﬁc
regions of the prtH and prtH2 genes both present in L. helveti-
cus CNRZ32, showed that BGRA43 possesses only the prtH gene,
sharing 98.9% of identity with the same gene of CNRZ32. The
hypothesis that PrtH is most probably the only active proteinase in
the strain BGRA43 was further conﬁrmed after obtaining the pro-
teolytically inactive derivative of BGRA43 designated BGRA433.
Results showed that the derivative BGRA433 carries a deletion
within the prtH gene encoding the catalytic region of the pro-
teinase (Lozo et al., 2011). Recently, a study on distribution of CEP
paralogs among different strains of L. helveticus revealed that the
most common CEP gene is prtH3, compared to the prtH, prtH2,
and prtH4 (Broadbent et al., 2011). Only one strain tested in this
study has only prtH gene, but its proteolytic activity, biochemical
characterization and other features were not analyzed.
The fact that the strain BGRA43 possesses only the PrtH pro-
teinase, in contrast to other tested L. helveticus strains, could
be especially interesting in relation to the production of the
strain-speciﬁc bioactive peptides as a result of casein hydrolysis.
Mass spectrometry analyses of the peptides released after β-casein
hydrolysis by BGRA43 identiﬁed 22 peptides, varying from 5 to 46
amino acids. The uniqueness of the BGRA43 strain is reﬂected
in the observation that the released peptides originated from
the more hydrophilic N-terminus portion of β-casein, as well as
that the numerous cleavages of β-casein occurred after phenylala-
nine. The peptides identiﬁed after 24 h of β-lactoglobulin (BLG)
hydrolysis varied from 5 to 17 amino acids; most of them had a
hydrophobic amino acid on their C-terminus. Interestingly, the
obtained results show that one of the three major allergenic epi-
topes of BLG at the Val41, Tyr42, and Val43 positions is hydrolyzed
by the BGRA43 crude extract (Lozo et al., 2011; Strahinic et al.,
2012). Moreover, four protein fractions released during BGRA43
milk fermentation exhibited an inhibitory effect on human mono-
cyte RB, as well as anti-inﬂammatory effects on the Nd-THP-1
monocyte cell line due to the down-regulation of TNF-α or IL-6
production (Tompa et al., 2010).
According to the FAO/WHO guidelines (FAO/WHO, 2006),
the main criterion for probiotic selection and application is the
survival of the bacterial cells during their passage through the GI
tract. The strain BGRA43 was examined in a chemically simulated
GIT transit, which included an assessment of its survival in gastric
and intestinal juices. The obtained results show that L. helveticus
BGRA43 survived GIT passage much better when it was included
in a food matrix (skimmed milk), probably due to the buffering
and protective effect of the skimmed milk. While the strain could
not survive the simulated GIT conditions in a saline buffer, the
survival of BGRA43 in simulated gastric juice supplemented with
skimmed milk during 90 min of incubation was 100%. The ﬁrst
short exposure to bile salts (10 min, 0.6%) reduced the bacterial
viability by three log units, but after lowering the concentration
of bile salts to 0.3%, the number of surviving bacteria was higher
(Strahinic et al., 2012).
To evaluate the hydrophobic/hydrophilic cell surface properties
of L. helveticus BGRA43, the afﬁnity of the strain to the organic sol-
vents hexadecane and chloroform was tested. Preliminary results
pointed out a high afﬁnity for both 70% hexadecane and 75%
chloroform which is in agreement with values obtained for other
human isolates (Ocana et al., 1999).
Another criterion provided by the FAO/WHO guidelines for
probiotic evaluation is the ability of a strain to colonize tran-
siently the intestinal mucosa. Therefore, the adhesion ability
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of L. helveticus BGRA43 to the Caco-2 epithelial intestinal cell
line was determined. As controls, the exopolysaccharide (EPS)-
producing strain L. paraplantarum BGCG11 and its non-ropy
derivative BGCG11-NB1 were used (Nikolic et al., 2012). The
BGCG11 strain, as was shown previously, has an adherence prop-
erty similar to the well-known probiotic strain L. rhamnosus GG.
The derivative BGCG11-NB1 showed signiﬁcantly higher adher-
ence to epithelial intestinal cell lines compared toGGandBGCG11
strains. It seems that the EPS synthesized by BGCG11 strain covers
the producing strain and hinder bacterial adhesion to enterocytes
whereas in the absence of EPS other surface molecules could have
been exposed and therefore act as adhesins. In general, the adhe-
sion of BGRA43 to theCaco-2 cell linewas similar to the adherence
of the derivative BGCG11-NB1, and signiﬁcantly higher (p< 0.05)
than the adherence of BGCG11 (Figure 1A). These ﬁndings indi-
cated that the BGRA43 strain has a signiﬁcantly better adherence
trait than the probiotic and reference strain L. rhamnosus GG.
The capability of the L. helveticus BGRA43 strain inactivated
by UV-radiation to elicit the immune response was tested by
examining the induction of proliferation of gut-associated lym-
phoid tissue (GALT) isolated from rats. The proliferation indices
of GALT measured in the presence of BGRA43 and the L. para-
plantarum BGCG11 strain, which served as a positive control,
show that in the absence of stimulus the presence of both strains
signiﬁcantly (p < 0.05) decreased the proliferation of GALT in
comparisonwith the control (Figure 1B). The results show that the
strain BGRA43 has a strong immunomodulatory effect, revealed
as a reduction in the proliferation of lymphocytes, and that it
could play a role in the suppression of the immune response in
vivo. Taking into account that the immunomodulatory ability
of probiotics is not effective in all human populations it could
be assumed that the strain BGRA43, which possesses a poten-
tial immunosuppressive effect, could be speciﬁcally used in a
diet of autoimmune disorder patients that present an increased
inﬂammatory status. However, according FAO/WHO and EFSA
recommendations, before strains such as BGRA43 can be used
for human consumption the strain needs to be tested in human
clinical trials.
TECHNOLOGICAL PROPERTIES OF L. helveticus BGRA43
Lactobacillus helveticus strains are traditionally used for the pro-
duction of different types of cheeses primarily for long-ripening
cheeses such as Parmesan, Emmental, Grana, Provolone, and
Gruyere (Torriani et al., 1994; Giraffa et al., 1998; Giraffa and
Neviani, 1999; Rossetti et al., 2008). During our work, we tried
to apply BGRA43 as a starter in dairy fermentation to obtain a
high-quality yogurt-like product.
The ability of BGRA43 to grow and curdle milk was initially
tested in reconstituted skim milk (RSM). L. helveticus BGRA43
exhibited rapid growth at 37◦C and 42◦C in RSM; after 6 h
of growth the bacterial culture reached approximately 3 × 108
CFU/ml (Banina et al., 1998). The growth of BGRA43 in a chemi-
cally deﬁnedmedium(CDM)containing either inulin ornutrimas
carbohydrate source, was tested in parallel. These two fructans are
dietary ﬁbers exploited as potential prebiotic stimulators of intesti-
nal bacterial growth. BGRA43 displayed very satisfactory growth
in the presence of either inulin or nutrim, even when they were
the sole carbon source. The total cell number was approximately
107 CFU/ml and was comparable to the cell number obtained
when the monosaccharides, glucose and lactose, were used in
CDM as a carbon source.
The fermentation ability of BGRA43 in various milk sources
on a laboratory scale was examined. For this purpose, aside from
cultivation by RSM, commercial UHT sterilized whole cow’s milk
(WCM), obtained from a local supermarket and whole goat’s milk
(WGM), obtained from a local farm, were used. Furthermore,
the fermentation ability of BGRA43 in RSM, WCM, and WGM
containing inulin (1%) or nutrim (1%) was also tested. At the
end of a 4 h fermentation at 42◦C, the number of viable cells
in each of the nine milk combinations increased from 106 to
108 CFU/ml, while the pH values ranged between 4.35 and 4.69,
depending on the milk. At the same time, the titratable acidity of
FIGURE 1 | Mean values of the adhesion (%) of Lactobacillus
helveticus BGRA43 and control strains Lactobacillus paraplantarum
BGCG11 and its non-ropy derivative BGCG11-NB1 to the human
epithelial intestinal Caco-2 cell line.The statistical difference
(p < 0.5) between BGRA43 and BGCG11 was determined by Student’s
t -test (A). Proliferation (%) of GALT isolated from the rat was co-cultured
for 4 days in the presence of UV-irradiated Lactobacillus helveticus
BGRA43 and the control strain Lactobacillus paraplantarum BGCG11
at a bacteria : cell line ratio of 5:1. The statistical differences (p < 0.05)
between each stimuli and the control (L-cells: GALT lymphocytes
maintained in RPMI-medium) were determined by Student’s
t -test (B).
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the obtained yogurt-like products was measured. Acidity varied
among the products. Thus, at the end of fermentation, acid-
ity did not exceed 27.6◦SH, 39.2◦SH, and 29.6◦SH for products
obtained in RSM, WCM, and WGM, respectively. Similar results
were obtained for the remaining fermented products containing
inulin or nutrim. It is worthwhile mentioning that the highest vis-
cosity was observed in yogurt-like products prepared with either
inulin or nutrim. This trend of viscosity was maintained even
after 7 days of storage at 4◦C. During the same storage condi-
tions, the viable count of BGRA43 was 106 CFU/ml in all of the
tested product samples. These properties lend further support for
the use of BGRA43 as a starter culture strain. Finally, after 7 days
of storage, the yogurt-like products made from RSM, WCM, and
WGM, all of which contained 1% inulin, retained sufﬁcient acidity
and received high scores by sensory analysts, which was not the
case when nutrim was present (Strahinic et al., 2012). A test on
yogurt-like production using BGRA43 as starter under industrial
conditions was performed in one private SME. Obtained product
showed almost the same sensory characteristics as that produced
on laboratory scale.
CONCLUSION
In this mini-review, we present the key features of human intesti-
nal isolate L. helveticus BGRA43. This isolate is potential probiotic
strain that can ﬁnd application in dairy industry. The optimal
growth of this auto-aggregating strain is between 37 and 42◦C
in either MRS medium or skimmed milk. During its growth,
BGRA43 cells show strong antimicrobial potential against various
sporogenic andpathogenic bacteria, probably due to rapid increase
of organic acids in the growth medium. Under optimal condi-
tions, PrtH proteinase from BGRA43 completely hydrolyze all
three casein fractions. In addition, BGRA43 cells are able to
hydrolyze BLG and reduce its allergenicity, thus contributing to
better digestibility – especially in people allergic to cow’s milk.
BGRA43 cells are sensitive to gastric and intestinal conditions, but
when applied in skimmed milk that serves as a protector, they
survive simulated digestion. More than 70% of BGRA43 bac-
teria adhere to non-polar solvents, hexadecane and chloroform,
classifying it as a high hydrophobic strain. Strong adhesion abil-
ity of BGRA43 to intestinal epithelial cell lines was subsequently
conﬁrmed in vitro with Caco-2 cell line.
Four oligopeptides showing anti-inﬂammatory effect were
detected after BGRA43 milk fermentation. Moreover, reduction
of lymphocytes proliferation conﬁrmed that BGRA43 cells possess
strong immunosuppressive potential.
Finally, technological properties of this strain were also sat-
isfactory when tested on a laboratory and small industrial scale.
However, for application as starter culture in production of fer-
mented milk products, further experiments on a larger industrial
scale are necessary.
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